{
  "Q0": "BRCA1/BRCA2 testing",
  "Q1": "Yes",
  "Q2": "Yes",
  "Q3": "No",
  "Q4": "Yes",
  "Q4_followup": {
    "match_criteria": "No",
    "guidelines": "NCCN"
  },
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "No",
  "Q8": "Yes",
  "Q8_followup": {
    "alternative_test": "Multigene panel testing"
  },
  "Q9": "Yes",
  "Q9_followup": {
    "relevant_family_history": "No"
  },
  "Q10": "No",
  "Q10_followup": [
    "Risk Assessment"
  ],
  "Q11": "Yes",
  "Q12": "No",
  "Q13": "Yes",
  "Q14": "Yes",
  "Q14_followup": {
    "CPT_code": "81162"
  },
  "Q15": "No",
  "Q16": "No",
  "Q17": "The provider must complete the Aetna Breast and Ovarian Cancer Susceptibility Gene Prior Authorization Form and submit it along with the Laboratory's Test Requisition Form to Aetna for precertification. Documentation of specific cancer diagnosis in the proband(s) and pertinent medical records may be required prior to authorization. A summary indicating how this testing will change the immediate medical care of the member must also be included with the Prior Authorization request.",
  "match": true
}